A MULTI-CENTER, OPEN-LABEL, EXPLORATORY STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN SUBJECTS ≥1 MONTH TO <18 YEARS WITH EPILEPSY SYNDROMES ASSOCIATED WITH GENERALIZED SEIZURES
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2019
Price : $35 *
At a glance
- Drugs Lacosamide (Primary)
- Indications Generalised seizures
- Focus Therapeutic Use
- Sponsors UCB
- 24 Apr 2018 Status changed from active, no longer recruiting to completed.
- 06 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 08 Jun 2017 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.